Destination Wealth Management Increased Abbott Labs (ABT) Position By $545,256; Salem Communications (SALM) Has 0.58 Sentiment

Abbott Laboratories (NYSE:ABT) Logo

Destination Wealth Management increased Abbott Labs (ABT) stake by 3.04% reported in 2018Q4 SEC filing. Destination Wealth Management acquired 7,573 shares as Abbott Labs (ABT)’s stock rose 7.95%. The Destination Wealth Management holds 256,823 shares with $18.58M value, up from 249,250 last quarter. Abbott Labs now has $140.27 billion valuation. The stock increased 1.11% or $0.88 during the last trading session, reaching $79.86. About 11.99 million shares traded or 78.64% up from the average. Abbott Laboratories (NYSE:ABT) has risen 33.73% since March 17, 2018 and is uptrending. It has outperformed by 29.36% the S&P500. Some Historical ABT News: 23/03/2018 – ABBOTT LABORATORIES’ ALERE TO PAY $33.2 MILLION TO RESOLVE U.S. JUSTICE DEPARTMENT PROBE; 03/05/2018 – Abbott Expands Cardiac Arrhythmias Portfolio With FDA Clearance Of Advanced Mapping Catheter; 19/03/2018 – ABBOTT-MINISTRY OF HEALTH LABOUR AND WELFARE IN JAPAN GRANTED NATIONAL REIMBURSEMENT FOR CO’S MITRACLIP THERAPY TO TREAT MITRAL REGURGITATION; 09/04/2018 – Books: `Berenice Abbott’ Captures a Large and Star-Studded Life; 29/03/2018 – ABBOTT INITIATES GUIDE-HF CLINICAL TRIAL USING CARDIOMEMS; 16/04/2018 – Abbott Laboratories expected to post earnings of 58 cents a share – Earnings Preview; 23/03/2018 – Abbott’s Alere resolves US diagnostic device probe for $33.2 mln; 18/04/2018 – Abbott Labs 1Q Net $418M; 22/03/2018 – Global Transcatheter Aortic Valve lmplantation (TAVI) Market Analysis & Outlook 2018-2022 with Profiles of Abbott Laboratories, Boston Scientific, Edwards Lifesciences & Medtronic – ResearchAndMarkets; 18/04/2018 – Abbott Labs 1Q EPS 23c

Salem Communications Corp (SALM) investors sentiment increased to 0.58 in Q4 2018. It’s up 0.08, from 0.5 in 2018Q3. The ratio improved, as 15 investment managers started new or increased equity positions, while 26 reduced and sold stock positions in Salem Communications Corp. The investment managers in our database now own: 6.66 million shares, down from 6.95 million shares in 2018Q3. Also, the number of investment managers holding Salem Communications Corp in top ten equity positions was flat from 0 to 0 for the same number . Sold All: 12 Reduced: 14 Increased: 8 New Position: 7.

The stock decreased 3.46% or $0.1 during the last trading session, reaching $2.79. About 35,838 shares traded. Salem Media Group, Inc. (SALM) has declined 31.53% since March 17, 2018 and is downtrending. It has underperformed by 35.90% the S&P500. Some Historical SALM News: 06/03/2018 – Winston-Salem State University Launches Groundbreaking Program to Spur Social Mobility; 22/04/2018 – DJ Salem Media Group Inc Class A, Inst Holders, 1Q 2018 (SALM); 15/03/2018 – A.M. Best Changes Credit Ratings of JSC Salem Insurance Company Following Regulatory Action; 15/03/2018 – Salem Media Group 4Q EPS 85c; 26/03/2018 – WAHA CAPITAL NAMES SALEM AL NOAIMI AS CHAIRMAN; 08/05/2018 – Salem Media Group, Inc. Announces First Quarter 2018 Total Revenue of $63.8 Million; 10/04/2018 – Rep. Johnson: U.S. Rep. Johnson tours Hickey Metal Fabrication in Salem; 27/03/2018 – REICH BROTHERS BUYS SALEM, OREGON FACILITY FOR ABOUT $80M; 15/03/2018 – Salem Media Group 4Q Net $22.4M; 15/03/2018 – C-SPAN to Visit Salem and Portland on March 21-23 in Partnership with Comcast

First Wilshire Securities Management Inc holds 0.29% of its portfolio in Salem Media Group, Inc. for 367,189 shares. Teton Advisors Inc. owns 550,000 shares or 0.13% of their US portfolio. Moreover, North Star Investment Management Corp. has 0.11% invested in the company for 387,290 shares. The Us-based Ancora Advisors Llc has invested 0.04% in the stock. Foundry Partners Llc, a Minnesota-based fund reported 299,680 shares.

Salem Media Group, Inc. operates as a multi-media firm in the United States. The company has market cap of $73.06 million. It operates in three divisions: Broadcast, Digital Media, and Publishing. It currently has negative earnings. The firm owns and operates radio networks, which produce and distribute talk, news, and music programming to radio stations, as well as sells commercial airtime to national advertisers and independent radio station affiliates.

More notable recent Salem Media Group, Inc. (NASDAQ:SALM) news were published by: Nasdaq.com which released: “Salem Media Group, Inc. (SALM) Ex-Dividend Date Scheduled for March 18, 2019 – Nasdaq” on March 15, 2019, also Seekingalpha.com with their article: “Salem Media Group, Inc. (SALM) CEO Edward Atsinger on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” published on March 13, 2019, Nasdaq.com published: “Wednesday Sector Laggards: Paper & Forest Products, Television & Radio Stocks – Nasdaq” on March 13, 2019. More interesting news about Salem Media Group, Inc. (NASDAQ:SALM) were released by: Businesswire.com and their article: “Salem Media Group, Inc. Announces Fourth Quarter 2018 Total Revenue of $67.2 Million – Business Wire” published on March 12, 2019 as well as Nasdaq.com‘s news article titled: “Why Salem Media Group (SALM) Could Be a Top Value Stock Pick – Nasdaq” with publication date: June 11, 2018.

More important recent Abbott Laboratories (NYSE:ABT) news were published by: Seekingalpha.com which released: “Abbott Labs: A Long-Term Wealth Creator – Seeking Alpha” on February 19, 2019, also Streetinsider.com published article titled: “Abbott (ABT) Says Late-Breaking Data Presentations at ACC Highlight its Leading Cardiovascular Portfolio – StreetInsider.com”, Seekingalpha.com published: “FDA OKs expanded use for Abbott valve repair device – Seeking Alpha” on March 14, 2019. More interesting news about Abbott Laboratories (NYSE:ABT) was released by: Globenewswire.com and their article: “Report: Developing Opportunities within Abbott Laboratories, American Express, Welbilt, Cinemark, Barnes Group, and Nevsun Resources — Future Expectations, Projections Moving into 2019 – GlobeNewswire” with publication date: February 27, 2019.

Destination Wealth Management decreased At&T Inc (NYSE:T) stake by 39,540 shares to 353,520 valued at $10.09 million in 2018Q4. It also reduced Vanguard Tax Managed Intl Fd (VEA) stake by 12,629 shares and now owns 1,418 shares. Ishares Tr (IUSB) was reduced too.

Since September 20, 2018, it had 1 insider buy, and 8 sales for $32.08 million activity. $12.42M worth of Abbott Laboratories (NYSE:ABT) shares were sold by Contreras Jaime. The insider Stratton John G bought $249,875. $127,044 worth of stock was sold by Bracken Sharon J on Friday, September 28. Salvadori Daniel Gesua Sive sold 5,000 shares worth $366,957. The insider Watkin Jared sold 65,000 shares worth $4.62M. Shares for $4.00 million were sold by Blaser Brian J on Thursday, September 20. WHITE MILES D had sold 142,341 shares worth $10.30M.

Investors sentiment decreased to 0.91 in Q4 2018. Its down 0.05, from 0.96 in 2018Q3. It turned negative, as 61 investors sold ABT shares while 576 reduced holdings. 143 funds opened positions while 434 raised stakes. 1.29 billion shares or 4.79% more from 1.23 billion shares in 2018Q3 were reported. Obermeyer Wood Investment Counsel Lllp holds 0.06% or 8,016 shares. Banced Corp reported 1.13% of its portfolio in Abbott Laboratories (NYSE:ABT). Northrock Prtn Lc owns 34,930 shares or 0.75% of their US portfolio. Court Place Advsrs Limited Liability Corp stated it has 0.39% in Abbott Laboratories (NYSE:ABT). Peak Asset Mgmt Ltd Limited Liability Company invested 0.46% in Abbott Laboratories (NYSE:ABT). Lathrop Inv Mngmt stated it has 7,572 shares. Ramsay Stattman Vela & Price Inc stated it has 131,434 shares or 3.97% of all its holdings. Beech Hill Advsr Incorporated holds 13,189 shares or 0.59% of its portfolio. Greatmark Inv Partners reported 4,417 shares or 0.11% of all its holdings. New York-based Guardian Life Of America has invested 0.06% in Abbott Laboratories (NYSE:ABT). Credit Suisse Ag invested 0.16% in Abbott Laboratories (NYSE:ABT). Cape Ann Comml Bank reported 0.97% in Abbott Laboratories (NYSE:ABT). Moreover, Ameriprise has 0.22% invested in Abbott Laboratories (NYSE:ABT). Weatherstone Capital Mgmt owns 7,966 shares for 0.19% of their portfolio. Scholtz And Limited Liability invested 4.14% of its portfolio in Abbott Laboratories (NYSE:ABT).

Salem Media Group, Inc. (NASDAQ:SALM) Institutional Positions Chart